Entecavir Anhydrous

CHEMBL713 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
277.3 g/mol
LogP
-1.3
Phase
4

The anhydrous form of entecavir, this antiviral medication blocks hepatitis B virus replication by interfering with the viral enzyme needed to copy its DNA. It is used to treat chronic hepatitis B.

आणविक भार

277.2800 g/mol

LogP

-1.30

TPSA

126.00 Ų

लिपिंस्की RO5

उत्तीर्ण

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21

InChI

InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1

Molecular Formula

C12H15N5O3

HBD / HBA

4 / 5

घूर्णनीय बंधन

2

भारी परमाणु

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

The anhydrous form of entecavir, this antiviral medication blocks hepatitis B virus replication by interfering with the viral enzyme needed to copy its DNA. It is used to treat chronic hepatitis B.

Yes, Entecavir Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL713. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135398508. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.